BackAgeX Therapeutics Overview
AgeX Therapeutics Inc

AgeX Therapeutics Discounted Cash Flow

DCF Analysis for AGE.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$-3.97

Current Fair Value

$-3.97
135.8% Downside

Overvalued by 135.8% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading